Simdax® is indicated for the short-term treatment of acutely decompensated severe chronic heartfailure (ADHF) in situations where conventional therapy is not sufficient, and in cases where inotropic support is considered appropriate. Read more.
Our section for healthcare professionals provides additional and useful information on Simdax®. Join us and register here.